Jeff Yass’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Jeff Yass’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,991	Closed	-$10K	–	14538
2022 Q3	$10K	Sell	30,991 -23,183	-43%	-$6.6K	﹤0.01%	12788
2022 Q2	$14K	Buy	+54,174	New	+$18.6K	﹤0.01%	12447
2021 Q1	–	Sell	-27,282	Closed	-$41K	–	13060
2020 Q4	$41K	Buy	+27,282	New	+$38.3K	﹤0.01%	10796

Jeff Yass's MITO Position: Q4 2022 in Review

Jeff Yass sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 30,991 shares — an estimated $10K sold.

Jeff Yass first reported a position in MITO in Q4 2020 and held it in 3 quarters. The position peaked at $41K in Q4 2020. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

Jeff Yass reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
Jeff Yass sold 30,991 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $10K.
Jeff Yass first reported a position in Stealth BioTherapeutics Corp. ADS in Q4 2020 and held it in 3 quarters.
Jeff Yass's Stealth BioTherapeutics Corp. ADS position peaked at $41K in Q4 2020.
0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.